[A case of rhinofacial entomophthoromycosis in Soudano-Sahelian tropical climate in Burkina Faso]

J Mycol Med. 2017 Jun;27(2):254-260. doi: 10.1016/j.mycmed.2017.01.002. Epub 2017 Feb 14.
[Article in French]

Abstract

We describe a rhinofacial entomophthoramycosis case in a sexagenarian (65 years old) housewife. She was immunocompetent and resident of Burkina Faso. She consulted both the service of dermatology and the service of stomatology of the Teaching Hospital of Bobo-Dioulasso in February 2016 for a diffuse facial tumefaction evolving over six months. This tumefaction was associated with headaches and a left nasal obstruction. Histological examination of the lesion showed an important and polymorphic inflammatory reaction. Also, a filamentous fungus with wide non-septated hyphae and right-angled fungal branching, consistent with mucormycosis was isolated. Mycological diagnosis based on fungal culture with Sabouraud medium without any antibiotic and cyclohexemide after incubation at 27°C and at 30°C was negative. Furthermore, it was not possible to amplify the DNA extracted from biopsy. Antifungal therapy based on the administration of fluconazole per os at 800mg/day was started allowing clinical improvement. This is the first case of a rhinofacial entomophtharomycosis documented in Bobo-Dioulasso. Rhinofacial entomophthoromycosis is largely unknown, even in tropical regions such as Burkina Faso. This lack of knowledge results in a delay in the diagnosis, and subsequently a bad prognosis. It is therefore urgent to improve knowledge on this disease to guide diagnostic steps, prognosis of outcome, and antifungal therapy.

Keywords: Bobo-Dioulasso; Burkina Faso; Entomophtharomycosis; Entomophthoramycose; Mycose rhinofaciale; Rhinofacial mycosis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Burkina Faso
  • Conidiobolus* / isolation & purification
  • Conidiobolus* / physiology
  • Facial Dermatoses / drug therapy
  • Facial Dermatoses / microbiology
  • Facial Dermatoses / pathology*
  • Female
  • Fluconazole / therapeutic use
  • Humans
  • Mucormycosis / drug therapy
  • Mucormycosis / microbiology
  • Mucormycosis / pathology
  • Nose Deformities, Acquired / drug therapy
  • Nose Deformities, Acquired / microbiology
  • Nose Deformities, Acquired / pathology*
  • Nose Diseases / drug therapy
  • Nose Diseases / microbiology
  • Nose Diseases / pathology
  • Tropical Climate
  • Zygomycosis / drug therapy
  • Zygomycosis / microbiology
  • Zygomycosis / pathology*

Substances

  • Fluconazole